Informace o publikaci

The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study

Autoři

ZELINKA Jiří BLAHÁK Jiří PEŘINA Vojtěch PACASOVÁ Rita TREGLEROVÁ Jana BULIK Oliver

Rok publikování 2021
Druh Článek v odborném periodiku
Časopis / Zdroj Biomedical Papers
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://biomed.papers.upol.cz/artkey/bio-202103-0013_the-use-of-platelet-rich-fibrin-in-the-surgical-treatment-of-medication-related-osteonecrosis-of-the-jaw-40-pa.php?back=%2Fsearch.php%3Fquery%3DZelinka%2Bin%253Aauth%2Bname%2Bkey%2Babstr%26sfrom%3D0%26
Doi http://dx.doi.org/10.5507/bp.2020.023
Klíčová slova medication related osteonecrosis of the jawplatelet rich fibrinsurgical treatment
Popis Medication-related osteonecrosis of the jaw (MRONJ) is defined as exposed bone in the maxillofacial region persisting for more than eight weeks in patients who are or were treated with antiresorptive or antiangiogenic agents and had no radiation therapy to the craniofacial region or obvious metastatic disease of the jaws. It is a recognised side effect of antiresorptive or antiangiogenic medication. To date, there is no specific gold standard treatment for MRONJ cases. The aim of this study was to evaluate the successful rate of surgical treatment with adjuvant local application of platelet rich fibrin.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info